149 related articles for article (PubMed ID: 6480115)
1. Adoptive transfer of immune enhancement of experimental ulcerative colitis.
Onderdonk AB; Steeves RM; Cisneros RL; Bronson RT
Infect Immun; 1984 Oct; 46(1):64-7. PubMed ID: 6480115
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus.
Onderdonk AB; Cisneros RL; Bronson RT
Infect Immun; 1983 Nov; 42(2):783-8. PubMed ID: 6642651
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Bacteroides vulgatus strains in the enhancement of experimental ulcerative colitis.
Onderdonk AB; Bronson R; Cisneros R
Infect Immun; 1987 Mar; 55(3):835-6. PubMed ID: 3818101
[TBL] [Abstract][Full Text] [Related]
4. Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs.
Breeling JL; Onderdonk AB; Cisneros RL; Kasper DL
Infect Immun; 1988 Jul; 56(7):1754-9. PubMed ID: 3384476
[TBL] [Abstract][Full Text] [Related]
5. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.
Bamba T; Matsuda H; Endo M; Fujiyama Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():45-7. PubMed ID: 8563888
[TBL] [Abstract][Full Text] [Related]
6. Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients.
Setoyama H; Imaoka A; Ishikawa H; Umesaki Y
Microbes Infect; 2003 Feb; 5(2):115-22. PubMed ID: 12650769
[TBL] [Abstract][Full Text] [Related]
7. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora.
Onderdonk AB; Franklin ML; Cisneros RL
Infect Immun; 1981 Apr; 32(1):225-31. PubMed ID: 7216487
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease induced by combined bacterial immunization and oral carrageenan in guinea pigs. Model development, histopathology, and effects of sulfasalazine.
Oestreicher P; Nielsen ST; Rainsford KD
Dig Dis Sci; 1991 Apr; 36(4):461-70. PubMed ID: 1672517
[TBL] [Abstract][Full Text] [Related]
9. Serogrouping of Bacteroides vulgatus by the agglutination test.
Okamura N; Miyazaki K; Chida T; Niwayama K; Nakaya R; Benno Y; Mitsuoka T
J Clin Microbiol; 1985 Jul; 22(1):56-61. PubMed ID: 4019743
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity.
Mills RH; Dulai PS; Vázquez-Baeza Y; Sauceda C; Daniel N; Gerner RR; Batachari LE; Malfavon M; Zhu Q; Weldon K; Humphrey G; Carrillo-Terrazas M; Goldasich LD; Bryant M; Raffatellu M; Quinn RA; Gewirtz AT; Chassaing B; Chu H; Sandborn WJ; Dorrestein PC; Knight R; Gonzalez DJ
Nat Microbiol; 2022 Feb; 7(2):262-276. PubMed ID: 35087228
[TBL] [Abstract][Full Text] [Related]
11. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis.
Matsuda H; Fujiyama Y; Andoh A; Ushijima T; Kajinami T; Bamba T
J Gastroenterol Hepatol; 2000 Jan; 15(1):61-8. PubMed ID: 10719749
[TBL] [Abstract][Full Text] [Related]
12. The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner.
Ó Cuív P; de Wouters T; Giri R; Mondot S; Smith WJ; Blottière HM; Begun J; Morrison M
Anaerobe; 2017 Oct; 47():209-217. PubMed ID: 28583864
[TBL] [Abstract][Full Text] [Related]
13. The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease.
Shiba T; Aiba Y; Ishikawa H; Ushiyama A; Takagi A; Mine T; Koga Y
Microbiol Immunol; 2003; 47(6):371-8. PubMed ID: 12906096
[TBL] [Abstract][Full Text] [Related]
14. Antibodies detectable by counterimmunoelectrophoresis against Bacteroides antigens in serum of patients with inflammatory bowel disease.
Helphingstine CJ; Hentges DJ; Campbell BJ; Butt J; Barrett JT
J Clin Microbiol; 1979 Mar; 9(3):373-8. PubMed ID: 88458
[TBL] [Abstract][Full Text] [Related]
15. OmpA variants affecting the adherence of ulcerative colitis-derived Bacteroides vulgatus.
Sato K; Kumita W; Ode T; Ichinose S; Ando A; Fujiyama Y; Chida T; Okamura N
J Med Dent Sci; 2010 Mar; 57(1):55-64. PubMed ID: 20437766
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases.
Fujita H; Eishi Y; Ishige I; Saitoh K; Takizawa T; Arima T; Koike M
J Gastroenterol; 2002; 37(7):509-16. PubMed ID: 12162408
[TBL] [Abstract][Full Text] [Related]
17. CD4(+) T lymphocytes mediate colitis in HLA-B27 transgenic rats monoassociated with nonpathogenic Bacteroides vulgatus.
Hoentjen F; Tonkonogy SL; Qian BF; Liu B; Dieleman LA; Sartor RB
Inflamm Bowel Dis; 2007 Mar; 13(3):317-24. PubMed ID: 17206701
[TBL] [Abstract][Full Text] [Related]
18. Sulphasalazine fails to prevent development of mucosal ulceration and 5-lipoxygenase activity in guinea-pigs with chronic inflammatory bowel disease induced by combined bacterial immunization and oral carrageenin.
Oestreicher P; Nielsen ST; Rainsford KD
J Pharm Pharmacol; 1992 Jun; 44(6):528-31. PubMed ID: 1359081
[TBL] [Abstract][Full Text] [Related]
19. The carrageenan model for experimental ulcerative colitis.
Onderdonk AB
Prog Clin Biol Res; 1985; 186():237-45. PubMed ID: 4034603
[No Abstract] [Full Text] [Related]
20. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli.
Rath HC; Wilson KH; Sartor RB
Infect Immun; 1999 Jun; 67(6):2969-74. PubMed ID: 10338507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
